|
|
Baxter International Inc (BAX) |
|
|
|
| |
Baxter International Inc 's Total Debt to Equity
BAX's quarterly Total Debt to Equity and Total Debt, Equity growth
Due to debt repayement of -5.99% Baxter International Inc improved Total Debt to Equity in second quarter 2024 to 1.67, above the Baxter International Inc 's average Total Debt to Equity.
Within Medical Equipment & Supplies industry in the second quarter 2024, 43 other companies have achieved lower Total Debt to Equity than Baxter International Inc in the II Quarter 2024. While Total Debt to Equity total ranking has deteriorated compared to the first quarter 2024 from 791 to 1173 .
Explain Debt to Equity Ratio?
What is the structure of BAX´s Total Debt?
How valuable is the BAX´s Equity?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BAX Total Debt to Equity |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Y / Y Equity Change |
36.89 % |
38.61 % |
43.65 % |
46.37 % |
-36.75 % |
| Y / Y Total Debt Change |
-21.71 % |
-16.46 % |
882.76 % |
0.37 % |
3939.95 % |
| Total Debt to Equity MRQ |
1.67 |
1.67 |
1.63 |
2.02 |
2.93 |
| BAX's Total
Ranking |
# 1173 |
# 791 |
# 340 |
# 2175 |
# 2756 |
| Seq. Equity Change |
-6.4 % |
-2.75 % |
3.7 % |
45.02 % |
-5.22 % |
| Seq. Total Debt Change |
-5.99 % |
-0.52 % |
-16.34 % |
0.06 % |
0.32 % |
| Total Debt to Equity second quarter 2024 Company Ranking |
| Within: |
No. |
| Medical Equipment & Supplies Industry |
# 44 |
| Healthcare Sector |
# 114 |
| Overall Market |
# 1173 |
| Total Debt to Equity Statistics |
| High |
Average |
Low |
| 2.95 |
0.74 |
0 |
| (Sep 30 2022) |
|
(Sep 30 2019) |
Cumulative Baxter International Inc 's Total Debt to Equity
BAX's Total Debt to Equity for the trailling 12 Months
BAX Total Debt to Equity |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Y / Y Equity TTM Growth |
36.89 % |
38.61 % |
43.65 % |
46.37 % |
-36.75 % |
| Y / Y Total Debt TTM Growth |
-21.71 % |
-16.46 % |
882.76 % |
0.37 % |
3939.95 % |
| Total Debt to Equity TTM |
1.75 |
1.98 |
2.24 |
1.98 |
2.2 |
| Total
Ranking TTM |
# 50
| # 29
| # 2012
| # 2671
| # 2878
|
| Seq. Equity TTM Growth |
-6.4 % |
-2.75 % |
3.7 % |
45.02 % |
-5.22 % |
| Seq. Total Debt TTM Growth |
-5.99 % |
-0.52 % |
-16.34 % |
0.06 % |
0.32 % |
On the trailing twelve months basis Due to debt repayement of -5.99% Baxter International Inc decreased Total Debt to Equity in the 12 months ending in II Quarter 2024 to 1.75, above the Baxter International Inc 's average Total Debt to Equity. Total Debt to Equity is the average cumulative value over the last four quarters.
Among companies in the Medical Equipment & Supplies industry 3, during the past 12 months, other companies have achieved lower Total Debt to Equity than Baxter International Inc . While Total Debt to Equity total ranking has deteriorated during the twelve months ending in the II Quarter 2024, compared to the prior period, from 29 to 50.
Explain Debt to Equity Ratio?
What is the structure of BAX´s Total Debt?
How valuable is the BAX´s Equity?
| TTM Total Debt to Equity Company Ranking |
| Within: |
No. |
| Within the Medical Equipment & Supplies Industry |
# 4 |
| Healthcare Sector |
# 9 |
| Within the Market |
# 50 |
| trailing twelve months Total Debt to Equity Statistics |
| High |
Average |
Low |
| 2.24 |
0.59 |
0 | | (Dec 31 2023) |
|
(Sep 30 2017) |
| Companies with similar Total Debt to Equity in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry | Total Debt to Equity | Jun 30 2024 MRQ Total Debt | Jun 30 2024 MRQ Equity | | Establishment Labs Holdings Inc | 4.30 | $ 193.732 Millions | $ 45.019 Millions | | 3m Company | 3.28 | $ 13,083.000 Millions | $ 3,988.000 Millions | | Neuronetics Inc | 3.08 | $ 59.758 Millions | $ 19.386 Millions | | Owens and Minor inc | 2.42 | $ 2,082.713 Millions | $ 860.702 Millions | | Apyx Medical Corporation | 2.25 | $ 33.628 Millions | $ 14.924 Millions | | Bioventus Inc | 2.03 | $ 383.282 Millions | $ 189.062 Millions | | Novocure Limited | 1.81 | $ 653.470 Millions | $ 361.750 Millions | | Zynex inc | 1.77 | $ 58.078 Millions | $ 32.816 Millions | | Baxter International Inc | 1.67 | $ 12,904.000 Millions | $ 7,708.000 Millions | | Strata Skin Sciences Inc | 1.59 | $ 15.114 Millions | $ 9.496 Millions | | Tandem Diabetes Care Inc | 1.49 | $ 347.932 Millions | $ 233.875 Millions | | Insulet Corporation | 1.40 | $ 1,397.800 Millions | $ 998.400 Millions | | Haemonetics Corporation | 1.35 | $ 1,223.586 Millions | $ 905.368 Millions | | Integra Lifesciences Holdings Corp | 1.14 | $ 1,747.597 Millions | $ 1,534.195 Millions | | Conmed Corporation | 1.10 | $ 965.890 Millions | $ 881.832 Millions | | Delcath Systems Inc | 1.07 | $ 4.491 Millions | $ 4.192 Millions | | Artivion Inc | 1.06 | $ 313.563 Millions | $ 295.056 Millions | | Dexcom Inc | 1.00 | $ 2,437.800 Millions | $ 2,434.300 Millions | | Cytosorbents Corporation | 0.82 | $ 13.673 Millions | $ 16.737 Millions | | P3 Health Partners Inc | 0.80 | $ 133.955 Millions | $ 166.840 Millions | | Icu Medical Inc | 0.79 | $ 1,605.822 Millions | $ 2,037.812 Millions | | Carlisle Companies Incorporated | 0.76 | $ 2,290.100 Millions | $ 3,004.300 Millions | | Paragon 28 inc | 0.75 | $ 110.553 Millions | $ 146.835 Millions | | Integer Holdings Corporation | 0.72 | $ 1,118.529 Millions | $ 1,553.910 Millions | | Bausch and Lomb Corp | 0.70 | $ 4,632.000 Millions | $ 6,580.000 Millions | | Dentsply Sirona Inc | 0.69 | $ 2,099.000 Millions | $ 3,064.000 Millions | | Infusystem Holdings Inc | 0.64 | $ 34.165 Millions | $ 53.487 Millions | | Merit Medical Systems Inc | 0.62 | $ 801.321 Millions | $ 1,282.445 Millions | | Henry Schein Inc | 0.60 | $ 2,502.000 Millions | $ 4,148.000 Millions | | Medtronic Plc | 0.58 | $ 27,865.000 Millions | $ 48,160.000 Millions |
|
